Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Research Conference 2019

About Conference


Cancer Research Conference 2019 welcomes every one of the individuals over the globe to participate in "17th International Conference on Cancer Research and Therapy" slated during February 27-28, 2019 at Seoul, South Korea.

Cancer Research Conference 2019 coordinates addressing the principle themes and in addition inevitable methodologies of oncology. This will be the biggest and most important worldwide gathering in which the program incorporates Medical Oncologists, whole medicinal group required in the field of tumor to learn estimations of oncology and exceedingly branches of disease will come to examine and discuss on various parts of the malignancy, potential outcomes and genuine research work and finish confirmation of oncology. This gathering manages the one of a kind technique for oncology and its inventive procedures. The occasion is a two day program and the gathering topic is "Towards the Innovations in the Cancer Treatment" and from now on, we are looking for a support of cutting edge thoughts which frames the feeling of our Medical gatherings.

Why to attend???

Join your nobles around the world focused on learning about Oncology and related advances, which is your single best opportunity to reach the largest gathering of participants from the  community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with a new research works, and receive name recognition at this 2 day event. World-renowned speakers, the most topical research, advances, and the newest updates in Oncology are hallmarks of this conference.

Target Audience:

  • Business Entrepreneurs Public
  • Health Professionals
  • Drug Manufacturing Companies
  • Radiation Therapist
  • Oncology Societies
  • Clinical Researchers
  • Leading world Doctors
  • Surgical and Medical Oncologists
  • Young Researchers
  • Students & Delegates

Sessions/Tracks

Conference Series LLC LTD invites all the participants across the globe to attend the “17th International Conference on Cancer Research and Therapy” slated during February 27-28, 2019 at Seoul, South Korea.

Cancer Research Conference 2019 is a global platform to discuss and learn about Cancer, Breast Cancer, Cancer Research, Cancer Biomarkers, Cancer stages, Cancer Genetics and Epigenetics, Clinical Trials in Cancer Treatment, Cancer Prevention & Therapy, Stem Cell Therapy, Chemotherapy, Cancer Immunotherapy, Robotic Surgery, Natural methods for treatment of cancer, Cancer Vaccines, Radiation Oncology, Cancer Awareness and Survival

Track 1: Cancer

Cancer, also called malignancy, is an abnormal growth of cells. Malignancy is a is a social event of infections of contaminations joining flighty cell change with the probability to ambush or spread to different parts of the body. These rise out of generous tumors, which don't spread to different parts of the body. Conceivable signs and symptoms consolidate a knock, interesting kicking the bucket, deferred hack, unexplained weight decrease, and a change in gut developments. Tobacco utilize is the reason for around 22% of malignancy passings. Another 10% are because of stoutness, terrible eating routine, absence of physical action, and unreasonable drinking of liquor. Different variables incorporate certain contaminations, presentation to ionizing radiation and ecological poisons. In the creating scene, 15% of growths are because of diseases, for example, Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus contamination, Epstein– Barr infection and human immunodeficiency infection.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 2: Breast cancer

Breast growth begins when cells in the bosom start to become wild. These cells generally shape a tumor that can frequently be seen on x-beam or felt as an irregularity. The tumor is harmful if the cells can develop into encompassing tissues or spread far off regions of the body. Breast tumor happens altogether in ladies, yet men can get bosom tumor, as well. On the off chance that tumor cells have spread to your lymph nodes, there is a higher possibility that the cells could have gone through the lymph framework and spread to different parts of your body. The more lymph hubs with breast malignancy cells, the more probable it is that the disease might be found in different organs. Along these lines, discovering growth in at least one lymph node regularly influences your treatment design. For the most part, you will require surgery to expel at least one lymph node to know whether the disease has spread. All things considered, not all ladies with malignancy cells in their lymph hubs create metastasis, and a few ladies with no disease cells in their lymph nodes create metastasis later.

Related Conferences: Cancer Symposium | Breast Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 3: Cancer Research

Cancer research is an examine into malignancy to recognize causes and create systems for counteractive action, analysis, treatment, and fix. Tumor explores ranges from the study of disease transmission, sub-atomic bioscience to the execution of clinical preliminaries to assess and think about utilizations of the different growth medications. These applications incorporate medical procedure, radiation treatment, chemotherapy, hormone treatment and immunotherapy and consolidated treatment modalities, for example, chemo-radiotherapy. Beginning in the mid-1990s, the accentuation in clinical malignancy inquire about moved towards treatments got from biotechnology look into, for example, tumor immunotherapy and quality treatment.

Related Conferences: Cancer Symposium | Cancer Research Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 4: Cancer Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis.  The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Related Conferences: Cancer Symposium | Cancer Biomarkers Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 5: Cancer Stages

Stage of cancer can be described by the extent of growth of cancer and based on size of cancer. Stage of cancer can be found be found by performing the tests. By these tests we can know even the extent of spread of cancer and how far it has spread to other adjacent organs. Staging of cancer should be clearly understood by the doctor so that the type of treatment to be given could be easily known. If the cancer is present at only one place then treatment like surgery or radiotherapy is sufficient to get rid of cancer completely. If there is spread of cancer to adjacent organs then the treatment to be given in such a way that it circulates the whole body. There will not be correct identification of cancer sometimes then doctors check the lymph nodes present near to the cancer for the presence of cancer cells, it is the sign that indicates that the cancer has begun to develop body.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 6: Cancer Genetics and Epigenetics

Epigenetics deals with the study of heritable changes in gene, that does not include changes to the basic DNA arrangement — an adjustment in phenotype without an adjustment in genotype — which influences how cells read the genes.  The study of epigenetic modifications to the cancer cells genome is called Cancer Epigenetics, that does not bring a change in the nucleotide sequence.

Risk expectation and prediction and cancer prevention, growth counteractive action are also promising and encouraging areas of Epigenetics.

A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.
During the cell’s transformation to cancerous cell, Epigenetic modifications are also more important like genetic mutations. Their manipulation brings a great promising approach for preventing, detecting and treatment of cancer.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 7: Clinical Trials in Cancer Treatment

Phase l trials are the final step in a long process that begins with research in a lab. Before any new treatment is used with people in clinical trials, researchers work for many years to understand its effects on cancer cells in the lab and in animals. They also try to figure out the side effects it may cause.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 8: Cancer Prevention & Therapy

Malignancy treatment portrays the treatment of tumor in a patient, regularly with surgery, chemotherapy or potentially radiotherapy. Directed treatments are likewise accessible for some disease composes. A malignancy patient may get a wide range of kinds of treatment, including those went for mitigating the manifestations of disease, for example, torment. Chemotherapy as a rule alludes to the utilization of pharmaceuticals or medications to treat disease. The possibility of having chemotherapy panics numerous individuals. Be that as it may, realizing what chemotherapy is, the manner by which it works and what's in store can frequently help quiet your feelings of trepidation. It can likewise give you a superior feeling of control over your disease treatment. Directed treatment is a unique sort of chemotherapy that exploits contrasts between typical cells and malignancy cells. It's occasionally utilized alone, however frequently other malignancy medications are utilized with focused treatment.

Related Conferences: Cancer Symposium | Cancer Therapy Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 9: Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Stem Cells and Tumours cancer cells also have the characteristic which is also associated with normal stems cells. Stem Cell Therapy is used to prevent the disease. Stems cells transplant is used to treat cancers like leukaemia, multiple myeloma & lymphoma. Cord Blood Stem and Cancer cord blood contains haematopoietic (blood) stem cell. They have long been used in stem cell treatments for leukaemia, blood and bone marrow disorders when chemotherapy is used.

Related Conferences: Cancer Symposium | Stem Cell Therapy Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 10: Chemotherapy

Chemotherapy (Chemo) is a sort of treatment that incorporates a pharmaceutical or blend of drugs to treat tumor. The objective of chemo is to stop or moderate the development of growth cells. Chemo is viewed as a foundational treatment. This implies it might influence your whole body. Chemo meds assault quickly developing malignancy cells, yet they can likewise influence solid cells that develop quickly. Chemotherapy is the use of any pharmaceutical to treat any malady. Regardless, to a large number of individuals, the word chemotherapy suggests drugs used for ailment treatment. It's every now and again condensed to "chemo." Surgery and radiation treatment expel, murder, or damage illness cells in a particular area, yet chemo can work all through the whole body. This infers chemo can pulverize harm cells that have spread (metastasized) to parts of the body a long way from the principal (fundamental) tumor.

Related Conferences: Cancer Symposium | Chemotherapy Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 11: Cancer Immunotherapy

Cancer immunotherapy (in some cases called immuno-oncology, shortened IO) is the utilization of the safe framework to treat tumor. Immune therapies can be sorted as dynamic, latent or cross breed (dynamic and detached). These methodologies abuse the way that disease cells regularly have atoms on their surface that can be identified by the safe framework, known as tumor-related antigens (TAAs); they are frequently proteins or different macromolecules (e.g. starches). Dynamic immunotherapy guides the invulnerable framework to assault tumor cells by focusing on TAAs. Inactive immunotherapies improve existing against tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes and cytokines.

Related Conferences: Cancer Symposium | Cancer Immunotherapy Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 12: Robotic Surgery

Robotic surgery is a type of minimally invasive surgery. “Minimally invasive” means that instead of operating on patients through large incisions, we use miniaturized surgical instruments that fit through a series of quarter-inch incisions. Cancer Sciences and Robotic Systems are very closely associated as the robotic technology enables the radiation oncologists to deliver high doses of radiation with pinpoint accuracy to a broad range of tumors throughout the body, including the lungs, prostate and pancreas.

When performing surgery with the da Vinci Si—the world’s most advanced surgical robot—these miniaturized instruments are mounted on three separate robotic arms, allowing the surgeon maximum range of motion and precision. The da Vinci’s fourth arm contains a magnified high-definition 3-D camera that guides the surgeon during the procedure. The system’s sophisticated software allows for tracking of the tumor and the ability to continually adjust the radiation treatment to account for patient or tumor movement.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences | Robotic Surgery Conferences

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 13: Natural methods for treatment of cancer

Natural medicine aims to restore body’s ability to protect, regulate and heal itself. This looks at your physical, mental and emotional wellbeing. It is also called as phytomedicine, phytotherapy or botanical therapy. Alternative therapy that is followed by the cancer patients is herbal medicine.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences | Tumour Conferences

 

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 14: Cancer Vaccines

Cancer vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences | Cancer Vaccine Conferences

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

Track 15: Radiation Oncology

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiotherapy/radiation therapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Nuclear medicine is a branch of medicine that uses radiation to provide information about the functioning of a person's specific organs or to treat disease. Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences | Radiation Oncology Conferences

World Oncologists Annual Conference on Medical Oncology, Radiation Oncology & Surgical Oncology during December 07-08, 2018 at Chicago, Illinois, USA; Global Meeting on Clinical Oncology and Radiology during March 27-28, 2019 at Hong Kong; Cancer Genomics Congress: New Era for Cancer Prevention during October 21-22, 2019 at Abu Dhabi, UAE; International Conference on Biomarkers and Cancer Targets during November 18-19, 2019 at Dubai, UAE; Global Annual Oncologists Meeting during April 04-05, 2019 at Auckland, New Zealand; Annual T-cell Lymphoma Forum during January 10 - 12, 2019  at  La Jolla, California; Cancer Research and Radiation Oncology during May 20-22, 2019 at Barcelona, Spain; World Summit on Cancer Research and Therapy during April 19-20, 2019 at Dubai, UAE; European Lung Cancer Congress at Geneva, Switzerland during April 10-13, 2019

Related Cancer Institutions:

University of Tokyo; National University of Singapore; Kyoto University; University of Hong Kong; Peking University; Seoul University; National Taiwan University; Osaka University; Tsinghua University; Duke-NUS Medical School; Asian Medical Institute; International Medical University; Taipei Medical University; Allianze University College of Medical Sciences; Mahidol University; Herat University Faculty of Medicine; Karaganda State Medical University; Perdana University Graduate School of Medicine; Chongjin Medical University; Nanyang Technological University

Track 16: Cancer Awareness and Survival

Increased cancer awareness improves survival. Social and Economic Impact also harm the quality of cancer care. People who are not financially not strong do not receive good treatment. Cancer symptom awareness and cancer survival are associated. Cancer Awareness Program is conducted by government and many organizations to bring the awareness in the people to decrease the cancer levels & towards all oncology programs. Campaigns should focus on improving awareness about cancer symptoms, especially in socioeconomically deprived areas.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences | Tumour Conferences

Euro Congress on Cancer Science & Cancer Therapy during March 07-08, 2019 at Barcelona, Spain; World Conference on Medical Oncology & Hematology during March 27-28, 2019 at Hong Kong; World Congress on Neonatal & Pediatric Oncology during April 1-2, 2019 at Auckland, New Zealand; Global Experts Meeting on Cancer Science & Therapy during April 29-30, 2019 at Seoul, South Korea; World Congress on Radiology and Oncology during April 08-09, 2019 at Abu Dhabi, UAE; Annual meeting on Women’s cancer at Honolulu, Hawaii during March 16-19, 2019; Clinical Immuno-Oncology Symposium during February 28-March 02, 2019 at California, USA; Annual Conference: Clinical Hematology & Oncology 2019 during February 16-19, 2019 at San Diego, USA; International Conference on Cancer Research and Pharmacology during March 11-12, 2019 at Singapore; International Conference on Clinical Oncology and Molecular Diagnostics during June 17-18, 2019 at Rome, Italy

Related Cancer Institutions:

ESO - European School of Oncology; Kharkiv National Medical University; Medical University – Plovdiv; Medical University – Pleven; Bukovinian State Medical University; Technical University of Munich; University of Berlin; University of Amsterdam; Erasmus University Rotterdam; Leiden UniversityRWTH Aachen University; University of Groningen; Utrecht University; University of Tübingen; Yerevan State Medical University; University of Copenhagen; Maastricht University; Medical University of Vienna; University of Milan; University of Barcelona

Track 17: Precision Cancer Medicine

Precision medicine is the tailoring of medical treatment to the individual characteristics of each patient and his or her disease. Moreover, through the precision medicine approach, the treatment of each patient can be focused on drugs most likely to benefit him or her, sparing the patient the cost and potential harmful side effects from drugs that are unlikely to be beneficial. Oncology has been leading precision medicine efforts largely because of our immense knowledge of the role of genetic mutations in the development and progression of cancer. Precision medicine enables to approach detection, diagnosis and treatment in an in-depth way to determine how a cancer develops, grows and spreads.

Related Conferences: Cancer Symposium | Cancer Conferences | Cancer Meetings | Cancer Congress  | Cancer Summit | Oncologists Meetings | Oncology Conferences | Precision Medicine Conferences

Global Summit on Oncology & Cancer during May 6-7, 2019 at Tokyo, Japan; 15th World Congress on Blood Cancer during May 09-10, 2019 at Amsterdam, Netherlands; International conference on Cancer Science and Diagnostics during May 13-14, 2019 at Osaka, Japan; International Conference on Oncodiagnostics and Cancer Research during June 17-18, 2019 at Brisbane, Australia; Euro-Global Summit on Cancer Therapy & Radiation Oncology during July 25-27, 2019 at London, UK; European Multidisciplinary Colorectal Cancer Congress during March 9-11, 2019 at Lisbon, Portugal; Pediatric CNS Tumors in the Molecular Era on March 08, 2019 at New York, USA; Annual Miami Breast Cancer Conference during March 07-10, 2019 at Florida, USA; American Association for Cancer Research during March 29-April 03, 2019 at Georgia, USA; Tracking Cancer: Detection and Monitoring from Diagnosis to Therapy during February 04–06, 2019 at Barcelona, Spain

Related Cancer Institutions:

Stanford University; Johns Hopkins School of Medicine; UCSF School of Medicine; Duke University ; Yale School of Medicine; Harvard Medical School; UNC School of Medicine; UT Southwestern Medical School; The University of Chicago Pritzker School of Medicine; Maryland School of Medicine; University of Cincinnati Academic Health Center; University of Wisconsin School of Medicine; University of Minnesota Medical School; Stony Brook School of Medicine; Vermont College of Medicine; Wayne State School of Medicine; Emory University: School of Medicine; University of Utah School of Medicine; Vanderbilt University; Penn State Hershey College of Medicine; Alabama School of Medicine; UMASS School of Medicine; Rutgers New Jersey Medical School; Oklahoma College of Medicine

 

 

Market Analysis

Global Oncology or the Cancer Drugs Market is relied upon to gather $111.9 billion by 2020, enrolling a CAGR of 7.1% amid the gauge time frame 2014 to 2020. Late advance in organic treatments has augmented the size of remedial focuses for treatment of disease with the distinguishing proof of tumor cell particular qualities. Immunotherapies/biologics are developing as potential treatments to locate the lasting cure for different disease sorts. Among different biologics, drugs in view of monoclonal antibodies (mAbs) have increased noteworthy consideration as of late because of their high viability.

Worldwide disease drugs advertise represented $78,238.9 million of every 2015. The disease drugs showcase is driven by the developing commonness of different sorts of malignancy, expanding interest of natural and focused on tranquilize treatments, ceaseless patent expiry of key growth drugs and the rising effect of biosimilars. Be that as it may, the high cost of medication advancement, the danger of disappointment and the unfriendly impacts of tumor sedate treatment, especially chemotherapy, blocks the market development. Created countries have actualized strict directions for the outline and improvement of malignancy drugs. USFDA and European Union have attempted noteworthy activities to fuel the development of the disease drugs advertise by giving pre-showcase endorsement to potential medications under clinical improvement. Asia-Pacific and LAMEA are promising locales for directing clinical trials due a huge populace base and the minimal effort of clinical trials when contrasted with North America and Europe. By and by, progression of malignancy sedate research inferable from organic/directed treatments and customized medications hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating tumor drugs.

Why Seoul?

Seoul, officially the Seoul Special Metropolitan City, is the capital and largest metropolis of South Korea. Seoul is the hub of Cancer Institutes and center for Cancer Research. In recent years, the number of international students for Cancer Research at Seoul's universities has risen rapidly.

Funds Providing Organizations:

  • American Brain Tumor Association (ABTA)
  • ACT Brain Tumor
  • Ben and Catherine Ivy Foundation
  • Brain Tumor Foundation of Canada (BTFC)
  • Brain Tumor Funder's Collaborative
  • Childhood Brain Tumor Foundation
  • Concern Foundation
  • Congressionally Directed Medical Research Programs
  • Gold Hirsh Foundation
  • Grey Ribbon Crusade
  • Matthew Larson Foundation
  • National Brain Tumor Society
  • NBTS & AANS/CNS Section on Tumors
  • Pediatric Brain Tumor Foundation
  • Pediatric Oncology Grants\
  • Sontag Foundation

Key Market Players across the Globe:

  •     AstraZeneca
  •     Antisense Pharma
  •     EMD Serono Inc
  •     GlaxoSmithKline
  •     Bristol-Myers Squibb
  •     Pfizer Inc.
  •     F. Hoffmann-La Roche Ltd  Novartis AG

Conference highlights:

  • Pathophysiology of Cancer
  • Neurological Cancer
  • Oropharyngeal Cancer
  • Blood and Bone Cancer
  • Lung cancer
  • Renal and Hepatocellular cancer
  • Breast Oncology
  • Pancreatic and Colorectal Cancer
  • Reproductive Cancers
  • Cancer Therapy
  • Cancer Screening & Diagnosis
  • Cancer: Innovations
  • Nursing Oncology

Major Cancer Associations across the Globe:

  • American Association for cancer research
  • American Neuroma Association
  • Cancer Research Institute
  • National Cancer Society of Malaysia
  • National Cancer Institute
  • Cancer Research UK
  • Association of oncology Social work
  • The Association for Cancer Surgery (BASO)
  • Global Initiative against HPV and Cervical Cancer       
  • Global Lung Cancer Coalition (GLCC)
  • International Gynecologic Cancer Society
  • Cancer Council Australia
  • Australian Cancer Research Foundation
  • Australian Cancer Foundation
  • Prostate Cancer Foundation of Australia
  • National Breast Cancer Foundation
  • Kids with Cancer Foundation
  • Australian Cervical Cancer Foundation
  • Cure Cancer Australia Foundation
  • Clinical Oncology Society of Australia
  • Children’s Cancer Foundation
  • Australian Gynaecological Cancer Foundation
  • Cure Brain Cancer Foundation
  • Cancer Associations in Japan:
  • Sapporo Cancer Seminar Foundation
  • Japanese Breast Cancer Society
  • Japan Society of Gynecologic Oncology
  • Japan Society of Clinical Oncology
  • Japan Lung Cancer Society
  • Japan Society for Neuro-Oncology
  • Chiba Cancer Center
  • Aichi Cancer Center
  • Higashi Sapporo Hospital
  • Tochigi Cancer Center
  • Kanagawa Cancer Centre
  • Shizuoka Cancer Center
  • Japanese Association of Cancer Registries
  • Lung Oncology Group in Kyushu
  • Japanese Foundation for Cancer Research

Statistical Analysis of cancer types:

Target Audience: Oncologists, Researchers, Academicians, Physicians, Post Docs, Students, Pharmacy Industries, Academic scientists, Industry professionals, Diagnostic laboratory professionals.

Top Cancer Centres in Singapore:

Cancer treatment centres in Singapore are generally located in both public and private hospitals. These units and medical centres specialise in the treatment of cancer (oncology).

  • Singapore Cancer Society
  • Raffles Hospital
  • Parkway East Hospital - Parkway Cancer Centre
  • Gleneagles Hospital - Parkway Cancer Centre
  • Tan Tock Seng Hospital
  • Singapore General Hospital
  • KK Women's and Children's Hospital
  • Mount Elizabeth Hospital - Parkway Cancer Centre
  • National Cancer Centre
  • National University Hospital
  • Changi General Hospital
  • National University Hospital
  • Ng Teng Fong General Hospital and Jurong Community Hospital
  • National University Cancer Institute, Singapore
  • National University Heart Centre, Singapore
  • National University Centre for Oral Health, Singapore (2019)
  • National University Polyclinics
  • Jurong Medical Centre

In 2010, the worldwide disease market was esteemed at $64 billion, with estimated Compound Annual Growth Rate development to $81 billion by 2016. The seven noteworthy disease markets (US, France, Malaysia, Italy, Spain, United Kingdom and Japan) spoke to ~69% of the 2010 worldwide tumor showcase ($43 billion). The US overwhelmed 2010 deals with a piece of the overall industry of 39.5% and the main ten organizations of the worldwide growth showcase spoke to 88.1% of the aggregate market.

The market esteem in Malaysia is worth $42 million, and development will be driven by malignancy treatment taking after early determination of growths and focused on treatment in the three noteworthy diseases - lung, bosom and colorectal. The Asia oncology medicate advertise incomes have developed at a CAGR of 3.3% from 2009-2014. Asia oncology sedate market will develop at an impressive CAGR and will surpass over USD 20 billion by 2017.

Market Value for Cancer Research in billion $

In light of innovation, the malignancy diagnostics market is sorted into stage based and instrument-based. The instrument-based portion is relied upon to represent a noteworthy share of the disease diagnostics showcase, by item, in 2015.

This report contemplates the worldwide disease diagnostics showcase for the estimate time of 2015 to 2020. This market is relied upon to reach $12.1 Billion by 2020 from $8.1 Billion in 2015 and is ready to develop at a CAGR of 11.9% amid the gauge time frame.

Past Conference Report

Asia Pacific Oncologists 2018

Conference Series LLC Ltd successfully anchored its leading "15th Asia Pacific Oncologists Annual Meeting" slated during September 05-06, 2018 at Radisson Hotel Narita in Tokyo, Japan.

Asia Pacific Oncologists 2018 is distinguished with the attendance of Editorial Board Members of supported Journals, Scientists, Young and Brilliant Researchers, Business Delegates and Talented Student communities representing more than 25 countries who made this conference rewarding and fecund.

Our 15th Asia Pacific Oncologists Annual Meeting was based on the theme “Towards the Innovations in the Cancer Treatment” which has encrusted the below scientific sessions:

  • Pathophysiology of Cancer
  • Neurological Cancer
  • Oropharyngeal Cancer
  • Dermatological Cancer
  • Blood and Bone Cancer
  • Lung cancer
  • Renal and Hepatocellular cancer
  • Breast Oncology
  • Pancreatic and Colorectal Cancer
  • Reproductive Cancers
  • Cancer Therapy
  • Cancer Scenario
  • Nursing Oncology

The conference received salutations & immense support was extended by the keynote lectures mentioned below:

  • Wassil Nowicky, Ukrainian Anti-Cancer Institute, Austria
  • Kakil Ibrahim Rasul, National Center for Cancer Care and Research, Qatar
  • Jae Pil Hwang, Soonchunhyang University Hospital, Republic of Korea

Conference Series LLC Ltd wishes to acknowledge with its deep sincere gratitude to all the supporters from the Editorial Board Members of our Open Access Journals, Keynote speakers, Valuable speakers, students, delegates for their contribution to make this event a huge success.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Oncology Research. 

Conference Series LLC Ltd therefore, is glad to announce its 17th International Conference on Cancer Research and Therapy slated during February 27-28, 2019 in Seoul, South Korea.

 Mark your calendars for the upcoming meeting; we are hoping to see you soon!!!!

 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date February 27-28, 2019

Speaker Opportunity

Supported By

Journal of Carcinogenesis & Mutagenesis: Open Access Journal of Cancer Science & Therapy: Open Access Journal of Integrative Oncology: Open Access

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos